Colorectal cancer survival among Ministry of National Guard-Health Affairs (MNG-HA) population 2009–2017: retrospective study

Alyabsi, Mesnad; Sabatin, Fouad; Ramadan, Majed; Jazieh, Abdul Rahman

doi:10.1186/s12885-021-08705-8

Table 1 Demographic and Clinical Characteristics by Diagnosis Period, MNGHA 2009-2017^a

From: Colorectal cancer survival among Ministry of National Guard-Health Affairs (MNG-HA) population 2009–2017: retrospective study

	Total		Diagnosis period
Characteristics	N^d	%, SD	2009–2011		2012–2014		2015–2017		P
Total	1012	100	288	28.46	395	35.47	329	32.51
Age (years)									0.0012^b
Mean (SD)	68.03	14.39	69.65	14.31	69.19	14.22	65.21	14.31
< =40	40	3.95	8	2.78	14	3.54	18	5.47
41–50	68	6.72	13	4.51	20	5.06	35	10.64
51–60	186	18.38	48	16.67	72	18.23	66	20.06
61–70	288	28.46	92	31.94	102	25.82	94	28.57
71–80	237	23.42	60	20.83	105	26.58	72	21.88
> =81	193	19.07	67	23.26	82	20.76	44	13.37
Gender
Female	430	42.49	127	40.51	161	40.76	142	43.16	0.65
Male	582	57.51	161	59.49	234	59.24	187	56.83	0.65
Marital status									0.44
Single	55	5.43	15	5.21	23	5.82	17	5.17
Married	748	74.91	224	77.78	294	74.43	240	72.95
Widowed/divorced	57	5.63	15	5.21	17	4.30	25	7.60
Unknown	142	14.03	34	11.89	61	15.44	47	14.29
Nationality									0.36
Non-Saudi	76	7.51	21	2.08	35	3.46	20	1.98
Saudi	936	92.49	267	97.92	360	96.54	309	98.02
Tumor Site									0.002
Right colon	184	18.18	42	14.58	67	16.96	75	22.79
Left colon	434	42.89	121	42.01	174	44.05	139	42.25
Colon-non specified	160	15.18	62	21.53	65	16.46	33	10.03
Rectum	234	23.12	63	21.87	89	22.53	82	24.92
Tumor Morphology									0.78^c
Adenocarcinoma (AC), NOS	854	84.39	238	82.64	339	85.82	277	84.19
Mucinous AC	63	6.23	18	6.25	23	5.82	22	6.69
Mucin-producing AC	12	1.19	4	1.39	2	0.51	6	1.82
Signet ring cell carcinoma	14	1.38	5	1.74	7	1.77	2	0.61
AC in villous/tubuvillous adenoma	16	1.58	6	2.08	5	1.27	5	1.52
Others	53	5.34	17	5.90	19	4.81	17	5.17
Tumor grade									0.48
Well differentiated	33	3.26	12	4.17	9	2.28	12	3.65
Moderately differentiated	774	76.48	222	77.08	296	74.94	256	77.81
Poorly differentiated/Anaplastic	67	6.62	15	5.21	29	7.34	23	6.99
Unknown	138
Stage at diagnosis									0.0002
Localized	227	22.43	72	18.23	111	28.10	44	13.37
Regional	441	40.61	111	37.63	146	36.96	154	46.81
Distant metastasis	338	33.41	96	33.33	127	32.15	115	34.95
Unknown	36	3.56	9	3.13	11	2.78	16	4.86
Basis of diagnosis									0.02^c
Histology of primary	972	96.05	275	95.49	381	96.46	316	96.04
Histology of metastases	28	2.77	8	2.78	9	2.28	11	3.34
Others	12	1.19	5	1.74	5	1.27	2	0.61
									0.65
Surgery
Yes	426	42.09	179	62.15	157	39.75	90	27.36
No	586	57.91	109	37.85	238	60.25	239	72,64
Chemotherapy									< 0.0001
Yes	411	40.61	180	62.5	172	43.54	79	24.01
No	601	59.39	108	37.5	243	56.46	250	75.99
Radiotherapy									0.007
Yes	95	9.39	40	13.89	32	8.10	23	6.99
No	917	90.61	248	86.11	363	91.99	306	93.01

^a Data represent colorectal cancer patients registered in MNG-HA hospitals system between 1 January 2009 and 31 December 2017
^b P-values refer to comparisons between years range using Chi-square test
^c P-values refer to comparisons between marital status groups using Fisher exact test
^d “N” total sample size

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us